Anne Derache

Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial

Anne Derache, Collins Iwuji, Kathy Baisley et al. · Clinical Infectious Diseases · 2018 · 59 citations · Full text

HIV Drug Resistance Mutations in Proviral DNA from a Community Treatment Program

Anne Derache, Hyoung‐Shik Shin, Maya Balamane et al. · PLoS ONE · 2015 · 52 citations · Full text

Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes.

Isabelle Malet, Cathia Soulié, Anne Derache et al. · PubMed · 2009 · 50 citations

Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis

Dami A. Collier, Collins Iwuji, Anne Derache et al. · Clinical Infectious Diseases · 2017 · 42 citations · Full text

Resistance-Associated Mutations to Etravirine (TMC-125) in Antiretroviral-Naive Patients Infected with Non-B HIV-1 Subtypes

Almoustapha Issiaka Maïga, Diane Descamps, Laurence Morand‐Joubert et al. · Antimicrobial Agents and Chemotherapy · 2009 · 41 citations · Full text